A detailed history of Venture Visionary Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Venture Visionary Partners LLC holds 11,935 shares of AZN stock, worth $897,750. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,935
Previous 12,052 0.97%
Holding current value
$897,750
Previous $939,000 1.06%
% of portfolio
0.04%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$76.67 - $87.62 $8,970 - $10,251
-117 Reduced 0.97%
11,935 $929,000
Q2 2024

Aug 13, 2024

BUY
$66.81 - $80.83 $12,159 - $14,711
182 Added 1.53%
12,052 $939,000
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $24,717 - $28,175
405 Added 3.53%
11,870 $804,000
Q4 2023

Feb 15, 2024

BUY
$61.89 - $69.28 $14,606 - $16,350
236 Added 2.1%
11,465 $772,000
Q2 2023

Jul 14, 2023

SELL
$69.91 - $75.81 $6,361 - $6,898
-91 Reduced 0.8%
11,229 $803,000
Q1 2023

Apr 13, 2023

BUY
$63.15 - $71.6 $3,536 - $4,009
56 Added 0.5%
11,320 $785,000
Q4 2022

Feb 09, 2023

SELL
$54.21 - $70.44 $65,052 - $84,528
-1,200 Reduced 9.63%
11,264 $763,000
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $6,044 - $15,475
-114 Reduced 0.91%
12,464 $683,000
Q1 2022

May 03, 2022

BUY
$55.72 - $67.12 $18,721 - $22,552
336 Added 2.74%
12,578 $834,000
Q2 2021

Aug 05, 2021

SELL
$48.42 - $60.18 $3,583 - $4,453
-74 Reduced 0.6%
12,242 $733,000
Q1 2021

Apr 27, 2021

BUY
$47.16 - $54.44 $119,267 - $137,678
2,529 Added 25.84%
12,316 $612,000
Q4 2020

Jan 27, 2021

BUY
$48.52 - $58.02 $474,865 - $567,841
9,787 New
9,787 $489,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Venture Visionary Partners LLC Portfolio

Follow Venture Visionary Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.